However, several cancer cells circumvent the suppressive effects of TGF-β by inactivation of essential components of the TGF-β signaling pathway, such as receptors or Smad, or downstream signaling alterations, through the interference of other signaling pathways. Here, TGFB1 is linked to cancer.